Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Mayer Brown ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
New EU Regulation Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use
Regulation (EU) 2019/5, which was published a few days ago in the Official Journal of the European Union, amends the EU pharmaceutical legal framework
European Union
4 Feb 2019
2
Europe—New Regulation (EU) 2019/5 Extends Financial Penalties To Entities Beyond The Marketing Authorization Holder And Updates The Legal Framework For Medicinal Products For Human Use
Regulation (EU) 2019/5, which was published a few days ago in the Official Journal of the European Union, amends the EU pharmaceutical legal framework by:
European Union
4 Feb 2019
3
European Union
13 Dec 2018
4
Europe—Brexit Alert on Cosmetic Products
On November 29, 2018, the European Commission published a Notice to Stakeholders on the "Withdrawal of the United Kingdom and EU rules ...
European Union
7 Dec 2018
5
European Commission's Update Of Guideline On Duplicate Marketing Authorizations To Cover Biosimilars
On May 18, 2018, the European Commission launched a public consultation on "Duplicate Marketing Authorisation for Biological Medicinal Products" in relation to updating its Note...
European Union
31 May 2018
6
Europe—Key Dates And Roadmap For Implementation Of New Rules On Medical Devices
This Legal Update highlights the key dates for the MDR and explains the Roadmap.
European Union
4 Dec 2017
7
Europe—The Draft New Definition Of "Similarity" For Orphan Products Is Out For Public Consultation Again
The European Commission (EC) has finally published the draft amendment to Commission Regulation No 847/2000 regarding the concept of "similar medicinal product" (Draft Amendment).
European Union
7 Nov 2017
8
European Commission Publishes Revised Guideline On Criteria For Orphan Designation Of Medicinal Products
Two important developments occurred in mid-November 2016 for the pharmaceutical industry in Europe: the European Commission published a revised guideline on orphan medicinal products...
European Union
5 Dec 2016
9
UK Supreme Court Decides When Making Spare Parts Amounts To Patent Infringement, And The Consequences For Failing To Register A Patent Licence
The UK Supreme Court has unanimously ruled on an important commercial activity for patentees and spare part manufacturers, namely when supplying replacement parts constitutes patent infringement.
UK
27 Mar 2013
10
Intellectual Property & Life Sciences 2013: Legal Developments You Need To Know About
This is a short guide to some of the key legal developments for intellectual property in the life sciences sector in 2013.
European Union
25 Jan 2013
11
SPCs And The European Jurisprudence On Patent Term Extensions
Patent extensions are vitally important in the life sciences industry.
UK
18 Dec 2012
12
An Important New Weapon In Pan-European Patent Disputes - The English Courts Can Hear Non-English Patent Infringement Cases
The English Patents Court has delivered a ground-breaking judgment which could change the way that European patent litigation is conducted.
UK
11 Dec 2012
13
Europe Determines When Email Disclosures Can Be Prior Art
The European Patent Office Technical Board of Appeal has ruled on what is increasingly an important component of the evidence forming prior art attacks, namely alleged disclosures by email.
European Union
1 Oct 2012
14
A Step Back From The Patent Cliff? The Court Of Justice Of The EU Rules On SPCs
The Court of Justice of the European Union ("CJEU", the new name for the ECJ) has today delivered its highly anticipated judgments on the grant of EU-wide Supplementary Protection Certificates ("SPCs") for medicinal products.
European Union
25 Nov 2011
15
UK Supreme Court Lowers The Threshold For Biologics Patents
The UK Supreme Court has handed down an important judgment that establishes when patents for biological materials will satisfy the test of industrial applicability.
UK
24 Nov 2011
16
Advocate General's Opinion Concerning the EU Harmonised Test For Granting An Extension Of The Term Of A Patent For Medicinal Products
The Advocate General has delivered her advisory opinion on questions referred to the European Court of Justice seeking clarification on the conditions for obtaining supplementary protection certificates ("SPCs") for medicinal products marketed in EU Member States.
European Union
29 Jul 2011
17
Update on the Patent Box consultation
The UK Government has commenced its second public consultation on the Patent Box proposal. The Patent Box is aimed at companies that obtain profits from patents and the current proposal is to introduce, from 1 April 2013, a preferential regime of a 10 per cent rate for profits arising from patents.
UK
 
29 Jun 2011
18
Budget 2011 – Update On The UK Patent Box Proposal
The UK Government has provided an update on the Patent Box proposal in the Budget, including announcing that draft legislation will be published in autumn 2011.
UK
28 Mar 2011
19
Competition Law and Intellectual Property Go Another Round
In a new judgment that further explores the application of competition law to intellectual property rights, the EU General Court has upheld a 2005 Commission decision finding that AstraZeneca abused a market-dominant position by blocking or delaying the entry of generic versions of its ulcer drug Losec.
European Union
 
6 Jul 2010
Links to Result pages
 
1